106 related articles for article (PubMed ID: 8804024)
1. Diagnostic evaluation of the substantia nigra.
McRitchie DA; Halliday GM; Pamphlett R
Neuropathol Appl Neurobiol; 1996 Jun; 22(3):228-32. PubMed ID: 8804024
[TBL] [Abstract][Full Text] [Related]
2. The pathology of Parkinsonism: a comparison of degenerations in cerebral cortex and brainstem.
Alvord EC; Forno LS; Kusske JA; Kauffman RJ; Rhodes JS; Goetowski CR
Adv Neurol; 1974; 5():175-93. PubMed ID: 4374061
[No Abstract] [Full Text] [Related]
3. [Therapy of Parkinson's disease 2008].
Deuschl G
MMW Fortschr Med; 2008 May; 150 Suppl 2():60-3. PubMed ID: 18678055
[No Abstract] [Full Text] [Related]
4. Iron in the Parkinsonian substantia nigra.
Gerlach M; Double K; Riederer P; Hirsch E; Jellinger K; Jenner P; Trautwein A; Youdim MB
Mov Disord; 1997 Mar; 12(2):258-60. PubMed ID: 9087993
[No Abstract] [Full Text] [Related]
5. Glial pathology but absence of apoptotic nigral neurons in long-standing Parkinson's disease.
Banati RB; Daniel SE; Blunt SB
Mov Disord; 1998 Mar; 13(2):221-7. PubMed ID: 9539333
[TBL] [Abstract][Full Text] [Related]
6. Alpha-synuclein redistributes to neuromelanin lipid in the substantia nigra early in Parkinson's disease.
Halliday GM; Ophof A; Broe M; Jensen PH; Kettle E; Fedorow H; Cartwright MI; Griffiths FM; Shepherd CE; Double KL
Brain; 2005 Nov; 128(Pt 11):2654-64. PubMed ID: 16000336
[TBL] [Abstract][Full Text] [Related]
7. Neuromelanin magnetic resonance imaging of locus ceruleus and substantia nigra in Parkinson's disease.
Sasaki M; Shibata E; Tohyama K; Takahashi J; Otsuka K; Tsuchiya K; Takahashi S; Ehara S; Terayama Y; Sakai A
Neuroreport; 2006 Jul; 17(11):1215-8. PubMed ID: 16837857
[TBL] [Abstract][Full Text] [Related]
8. An abortive from of Parkinson's disease?
Hubert JW; van Rossum JO
Psychiatr Neurol Neurochir; 1969; 72(6):525-31. PubMed ID: 5369243
[No Abstract] [Full Text] [Related]
9. Inversion recovery MRI in idiopathic Parkinson disease is a very sensitive tool to assess neurodegeneration in the substantia nigra: preliminary investigation.
Raff U; Hutchinson M; Rojas GM; Huete I
Acad Radiol; 2006 Jun; 13(6):721-7. PubMed ID: 16679274
[TBL] [Abstract][Full Text] [Related]
10. Expression profiling of substantia nigra in Parkinson disease, progressive supranuclear palsy, and frontotemporal dementia with parkinsonism.
Hauser MA; Li YJ; Xu H; Noureddine MA; Shao YS; Gullans SR; Scherzer CR; Jensen RV; McLaurin AC; Gibson JR; Scott BL; Jewett RM; Stenger JE; Schmechel DE; Hulette CM; Vance JM
Arch Neurol; 2005 Jun; 62(6):917-21. PubMed ID: 15956162
[TBL] [Abstract][Full Text] [Related]
11. Facial dystonia in pathologically proven multiple system atrophy: a video report.
Wenning GK; Quinn NP; Daniel SE; Garratt H; Marsden CD
Mov Disord; 1996 Jan; 11(1):107-9. PubMed ID: 8771082
[No Abstract] [Full Text] [Related]
12. Clinical neuropathological conference.
Dis Nerv Syst; 1967 Jun; 28(6):407-12. PubMed ID: 6033181
[No Abstract] [Full Text] [Related]
13. Early signs of neuronal apoptosis in the substantia nigra pars compacta of the progressive neurodegenerative mouse 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine/probenecid model of Parkinson's disease.
Novikova L; Garris BL; Garris DR; Lau YS
Neuroscience; 2006 Jun; 140(1):67-76. PubMed ID: 16533572
[TBL] [Abstract][Full Text] [Related]
14. Monomelic parkinsonian tremor caused by contralateral substantia nigra stroke.
Gonzalez-Alegre P
Parkinsonism Relat Disord; 2007 Apr; 13(3):182-4. PubMed ID: 16731026
[TBL] [Abstract][Full Text] [Related]
15. Serum uric acid and clinical progression in Parkinson disease: potential biomarker for nigrostriatal failure.
Schiess M; Oh I
Arch Neurol; 2008 Jun; 65(6):698-9. PubMed ID: 18541788
[No Abstract] [Full Text] [Related]
16. Parkinson's disease beginning before age 40.
Gershanik OS; Nygaard TG
Adv Neurol; 1990; 53():251-8. PubMed ID: 2173370
[No Abstract] [Full Text] [Related]
17. The pathology of Parkinsonism. Part I. Some new observations and correlations.
Forno LS; Alvord EC
Contemp Neurol Ser; 1971; 8():119-30. PubMed ID: 5162177
[No Abstract] [Full Text] [Related]
18. Topographical alterations of the midbrain and the substantia nigra following unilateral posteroventral pallidotomy in patients with Parkinson's disease using routine and multishot diffusion-weighted magnetic resonance imaging.
Adachi M; Kurimura M; Saito S; Hosoya T; Kayama T; Kato T
Neuroradiology; 2002 Jul; 44(7):579-85. PubMed ID: 12136359
[TBL] [Abstract][Full Text] [Related]
19. [Traumatic brain stem lesions with long-term survival. Contribution to the pathology of substancia nigra and the pontine syndrome].
Huhn B; Jakob H
Nervenarzt; 1970 Jul; 41(7):326-34. PubMed ID: 5453704
[No Abstract] [Full Text] [Related]
20. [Study on the fiber connection of the substantia nigra].
Masuda S
Shinkei Kenkyu No Shimpo; 1968 Dec; 12(4):839-44. PubMed ID: 5753734
[No Abstract] [Full Text] [Related]
[Next] [New Search]
